NCT00095004已完成3 期
A Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Examine the Efficacy of Rizatriptan 10 mg Tablet Administered Early During a Migraine Attack While the Pain is Mild
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 167
- 主要终点
- Percentage of patients who are pain free at 2 hours postdose
研究概览
简要总结
The purpose of this study is to test the effectiveness of an approved drug in the early treatment of migraine.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Six month history of migraine; attacks typically mild when they begin with 1-4 migraine attacks per month.
排除标准
- •Heart disease
- •High blood pressure
结局指标
主要结局
Percentage of patients who are pain free at 2 hours postdose
Tolerability as measured by subjective adverse experience reporting
次要结局
- Percentage of patients with 24 hour sustained pain freedom
- Percentage of patients requiring rescue medication between 2 & 24 hours
- Percentage of patients pain free at 30/45/60/90 minutes post dose
- Percentage of patients with associated symptoms at 2 hours
- Percentage of patients with functional disability at 2 hours
研究者
相似试验
已完成
3 期
Study to Test an Approved Product in the Early Treatment of Migraine (0462-065)MigraineNCT00092963Organon and Co529
已完成
1 期
Safety and Efficacy of Early Administration of Dexamethasone in High-risk SepsisSepsisNCT05136560CHA University102
尚未招募
4 期
RCT Study of Levosimendan Improving Prognosis of Cardiac ArrestHeart ArrestNCT05956431Peking University Third Hospital60
招募中
1 期
Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)Advanced Solid TumorMetastatic Solid TumorNCT05898399Artios Pharma Ltd181
已完成
1 期
Phase 1 Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)Systemic Lupus ErythematosusNCT00657007Human Genome Sciences Inc.70